You are currently viewing PVpharm to provide pharmacovigilance and CTIS support to the Center for Human Drug Research of the Netherlands (CHDR).

PVpharm to provide pharmacovigilance and CTIS support to the Center for Human Drug Research of the Netherlands (CHDR).

  • Post published:January 24, 2023

We are happy to announce that PVpharm have enter in a new agreement with Center of Human Drug Research (CHDR) to provide safety and regulatory consulting. This prestigious foundation, based in Leiden (NL) and with three decades of history, provide scientific and material support to first steps of the drug development in humans (phase I and II of Clinical trials).

Our collaboration will focus on helping about EMA’s Clinical Trial Information System (CTIS) and pharmacovigilance tasks, essential in these steps of drug development.

With different therapeutic areas of research, CHDR is a leading organization in this field, with projects as its study about use of medicinal cannabis in the treatment of neuropathic pain. PVpharm provides services in all the phases of the medicinal product life cycle, and we have different services for sponsors of clinical trials in the EU. For more information, please read more at https://pvpharm.com/pharmacovigilance/

Please contact us with any question https://pvpharm.com/contact/